Categories AlphaGraphs, Analysis, Earnings, Retail
Earnings preview: eBay might see positive momentum in Q2
eBay Inc. (NASDAQ: EBAY) is scheduled to report second quarter 2019 earnings results on Wednesday, July 17, after market close. Analysts project earnings of $0.62 per share, reflecting an increase of nearly 17% year-over-year. Revenue is estimated to increase by 1.3% to $2.67 billion.
The top line results are expected to benefit from growth in active buyers as well as healthy momentum in the payments and advertising businesses. The company’s business model, which pushes costs to suppliers, is expected to help drive margins.
eBay’s efforts to control costs, such as the reduction in marketing expenses, is likely to benefit earnings. However, the decline in gross merchandise volume (GMV) remains a concern. The company also faces stiff competition from larger rivals like Amazon (NYSE: AMZN) and Walmart (NYSE: WMT).
eBay has faced pressure from activist investors to take measures to enhance shareholder value. These include efforts to improve the performance of its StubHub and Classifieds businesses. Updates on this issue are worth keeping an eye on.
In the first quarter of 2019, eBay topped revenue and earnings estimates, with revenue rising 2% to $2.64 billion and adjusted EPS jumping 26% to $0.67. The company had a total of 180 million global active buyers, reflecting an increase of 4%. GMV dropped 4% to $22.6 billion. Last quarter, StubHub revenues remained flat while Classifieds revenue rose 4% versus the prior year.
For the second quarter of 2019, eBay has guided for revenues in the range of $2.64 billion to $2.69 billion. GAAP EPS is expected to be $0.41-0.45 while adjusted EPS is expected to be $0.61-0.63.
Based on a strong performance last quarter, the company raised its guidance for full-year 2019 to a range between $10.83 billion and $10.93 billion. GAAP EPS from continuing operations is estimated to be $1.94-2.04. Adjusted EPS is projected to be $2.64-2.70.
Shares of eBay have gained 42% year-to-date and 10% over the past three months.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on